Stratos Wealth Partners LTD. Purchases 236 Shares of Axon Enterprise, Inc $AXON

Stratos Wealth Partners LTD. boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 3.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 6,798 shares of the biotechnology company’s stock after acquiring an additional 236 shares during the period. Stratos Wealth Partners LTD.’s holdings in Axon Enterprise were worth $5,629,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. TCI Wealth Advisors Inc. bought a new stake in shares of Axon Enterprise in the second quarter valued at approximately $214,000. Kentucky Retirement Systems Insurance Trust Fund purchased a new position in Axon Enterprise in the 1st quarter valued at approximately $1,110,000. Duncker Streett & Co. Inc. raised its holdings in Axon Enterprise by 3.2% during the 2nd quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock valued at $12,006,000 after acquiring an additional 448 shares during the period. Quotient Wealth Partners LLC purchased a new stake in shares of Axon Enterprise during the first quarter worth $438,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Axon Enterprise by 11.8% in the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after acquiring an additional 154 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on AXON shares. Piper Sandler assumed coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price objective on the stock. Bank of America lifted their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Wolfe Research assumed coverage on shares of Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. Finally, JMP Securities reiterated a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. This represents a 6.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the transaction, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. The trade was a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Up 2.8%

Shares of NASDAQ AXON opened at $670.68 on Friday. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm’s 50 day simple moving average is $739.44 and its two-hundred day simple moving average is $718.36. The stock has a market capitalization of $52.65 billion, a P/E ratio of 165.60, a PEG ratio of 26.04 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same period in the previous year, the business posted $1.20 EPS. The business’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.